Curis Lifesciences Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Curis Lifesciences Ltd is ₹ 116.5 as of 06 May 15:30 . The p/e ratio of Curis Lifesciences Ltd changed from 0 to 0 over 8 quarters. This represents a CAGR of 0.0% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 8 quarters. This represents a CAGR of -100.00% The market cap of Curis Lifesciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Revenue of Curis Lifesciences Ltd is ₹ 9.12 crore as of Jun '24 .The Revenue of Procter & Gamble Health Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Curis Lifesciences Ltd is ₹ 2.73 crore as of Jun '24 .The EBITDA of Procter & Gamble Health Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Curis Lifesciences Ltd is ₹ 1.2 crore as of Jun '24 .The Net Profit of Procter & Gamble Health Ltd is ₹ 0 crore as of Jun '24 . The dividend payout of Curis Lifesciences Ltd changed from 0 % to 0 % over 8 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 8 quarters. This represents a CAGR of -100.00% .

About Curis Lifesciences Ltd

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar. Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Curis Lifesciences Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Curis Lifesciences Ltd or Procter & Gamble Health Ltd?

Market cap of Curis Lifesciences Ltd is 94 Cr while Market cap of Procter & Gamble Health Ltd is 8,854 Cr

What are the key factors driving the stock performance of Curis Lifesciences Ltd and Procter & Gamble Health Ltd?

The stock performance of Curis Lifesciences Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Curis Lifesciences Ltd and Procter & Gamble Health Ltd?

As of May 6, 2026, the Curis Lifesciences Ltd stock price is INR ₹116.5. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5334.05.

How do dividend payouts of Curis Lifesciences Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Curis Lifesciences Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.